Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-150.05M -40.22M -157.42M -174.24M
Depreciation & Amortization
473K 319K 168K 47K
Stock-Based Compensation
25.49M 32.98M 42.38M 63.36M
Other Working Capital
-7.33M 5.33M -301K -9.9M
Other Non-Cash Items
50.85M -84.66M 8.67M 16.06M
Deferred Income Tax
n/a n/a 5.07M 39.13M
Change in Working Capital
-9.2M 7.47M -3.33M -7.6M
Operating Cash Flow
-82.44M -84.12M -104.47M -63.25M
Capital Expenditures
-95K -590K -1.02M -1.13M
Cash Acquisitions
359K -443K n/a -52.94M
Purchase of Investments
-15M -185.26M -309.66M -23.66M
Sales Maturities Of Investments
82.01M 139.47M 226.83M -955K
Other Investing Acitivies
-7.83M -6.91M -3M -2.6M
Investing Cash Flow
59.17M -53.3M -86.85M -81.28M
Debt Repayment
5M n/a 15M 1.59M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.37M -8.36M 5.18M 2.42M
Financial Cash Flow
5.37M -8.36M 20.79M 409.86M
Net Cash Flow
-17.53M -145.58M -171.65M 265.02M
Free Cash Flow
-82.53M -84.71M -105.49M -64.37M